FDA Expands Pfizer Boosters For Ages 12 To 15 As Omicron Surges

The FDA has expanded the eligibility for Pfizer's COVID-19 booster shots to include children as young as 12, aligning with the return to school. The booster can now be administered five months after the last dose instead of six. The CDC is yet to make a decision on recommending boosters for younger teens. The timing is crucial as the Omicron variant spreads, and child hospitalizations rise. Many children remain unvaccinated, highlighting the importance of this booster expansion.

What has been observed regarding child hospitalizations related to COVID-19?

What decision is the CDC expected to make regarding booster shots for younger teens?